<DOC>
	<DOCNO>NCT00038545</DOCNO>
	<brief_summary>For patient relapsed refractory aggressive non-Hodgkin 's lymphoma</brief_summary>
	<brief_title>A Phase II Study Paclitaxel Topotecan With Filgrastim-SD/01 Support For Relapsed Refractory Aggressive Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>INCLUSION : Bidimensionally measurable current/refractory aggressive NHL ( Diffuse lg cell , diffuse mixed cell , follicular lg noncleaved , immunoblastic , Ki1+ALCL , peripheral Tcell lymphoma , mantle cell lymphoma &amp; transform lymphoma . ) No 3 prior treatment regimen . No antilymphoma therapy within past 3 week . Not eligible treatment high priority . Performance status &lt; 2 Zubrod , &gt; 60 Karnofsky . Good marrow reserve : ANC &gt; 1.5 x 10 ( 9 ) /L , platelet &gt; 100 x 10 ( 9 ) /L . Bilirubin &lt; 1.5mg/dL , SGOT , SGPT &lt; 2 x normal value . Serum creatinine &lt; 1.8 mg/dL . Age &gt; 18 yr . Signed informed consent . Life expectancy &gt; 12 week . No prior Taxane ( paclitaxel docetaxel ) , topotecan , CPT11 . No prior stem cell bone marrow transplantation . No prior second malignancy except basal cell carcinoma skin . EXCLUSION : Active prior history CNS lymphoma . Serious intercurrent medical illness require hospitalization . History primary/secondary immunodeficiency ( related malignant lymphoma treatment dependent functional immune system ) patient take immunosuppressive drug ( systemic corticosteroid ) . Prior exposure FilgrastimSD/01 . Women pregnant lactating . Participation another clinical trial . Positive HIV antibody . History prior sensitivity E. coli derive product ( filgrastim/neupogen ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>LYMPHOMA</keyword>
	<keyword>NON-HODGKINS</keyword>
	<keyword>AGGRESSIVE</keyword>
	<keyword>RELAPSED AND REFRACTORY</keyword>
</DOC>